$8.2 million grant advances on-demand male contraceptive development
Weill Cornell Medicine has received a four-year, $8.2 million grant from the National Institute of Child Health and Human Development (NICHD) to develop and test an experimental on-demand male contraceptive pill that temporarily stops sperm in their tracks
Read original article on The Medical News →Related news
-
Blood test can help clinicians better identify brain injury severity in patients
United Kingdom
-
Study links recreational cannabis legalization to rising heart attack admissions
United Kingdom
-
Standardized protocol enables safer kidney biopsies in high-risk patients
United Kingdom
-
Social determinants of health may increase kidney failure risk after critical illness
United Kingdom
-
Potassium binder helps dialysis patients manage dietary restrictions
United Kingdom
-
Fruits and vegetables may be a better option to improve kidney disease outcomes
United Kingdom
-
New clinical decision support tool aims to improve chronic kidney disease care
United Kingdom
-
Psilocybin reshapes brain connections through distinct cellular pathways
United Kingdom